Predictive Oncology Inc. (POAI)

Market Cap	8.36M
Revenue (ttm)	1.62M
Net Income (ttm)	-12.66M
Shares Out	8.93M
EPS (ttm)	-2.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,903
Open	0.9323
Previous Close	0.9485
Day's Range	0.9285 - 0.9485
52-Week Range	0.5500 - 3.0600
Beta	1.11
Analysts	Hold
Price Target	n/a
Earnings Date	May 13, 2025

About POAI

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvemen...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 24
• Stock Exchange: NASDAQ
• Ticker Symbol: POAI
• Website: https://www.predictive-oncology.com

Financial Performance

In 2024, Predictive Oncology's revenue was $1.62 million, a decrease of -0.24% compared to the previous year's $1.63 million. Losses were -$12.66 million, -9.44% less than in 2023.